PURPOSE: We hypothesized that reduced arousability (Richmond Agitation Sedation Scale, RASS, scores -2 to -3) for any reason during delirium assessment increases the apparent prevalence of delirium in intensive care patients. To test this hypothesis, we assessed delirium using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) and Intensive Care Delirium Screening Checklist (ICDSC) in intensive care patients during sedation stops, and related the findings to the level of sedation, as assessed with RASS score. METHODS: We assessed delirium in 80 patients with ICU stay longer than 48 h using CAM-ICU and ICDSC during daily sedation stops. Sedation was assessed using RASS. The effect of including patients with a RASS of -2 and -3 during sedation stop ("light to moderate sedation", eye contact less than 10 s or not at all, respectively) on prevalence of delirium was analyzed. RESULTS: A total of 467 patient days were assessed. The proportion of CAM-ICU-positive evaluations decreased from 53 to 31 % (p < 0.001) if assessments from patients at RASS -2/-3 (22 % of all assessments) were excluded. Similarly, the number of positive ICDSC results decreased from 51 to 29 % (p < 0.001). CONCLUSIONS: Sedation per se can result in positive items of both CAM-ICU and ICDSC, and therefore in a diagnosis of delirium. Consequently, apparent prevalence of delirium is dependent on how a depressed level of consciousness after sedation stop is interpreted (delirium vs persisting sedation). We suggest that any reports on delirium using these assessment tools should be stratified for a sedation score during the assessment.
PURPOSE: We hypothesized that reduced arousability (Richmond Agitation Sedation Scale, RASS, scores -2 to -3) for any reason during delirium assessment increases the apparent prevalence of delirium in intensive care patients. To test this hypothesis, we assessed delirium using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) and Intensive Care Delirium Screening Checklist (ICDSC) in intensive care patients during sedation stops, and related the findings to the level of sedation, as assessed with RASS score. METHODS: We assessed delirium in 80 patients with ICU stay longer than 48 h using CAM-ICU and ICDSC during daily sedation stops. Sedation was assessed using RASS. The effect of including patients with a RASS of -2 and -3 during sedation stop ("light to moderate sedation", eye contact less than 10 s or not at all, respectively) on prevalence of delirium was analyzed. RESULTS: A total of 467 patient days were assessed. The proportion of CAM-ICU-positive evaluations decreased from 53 to 31 % (p < 0.001) if assessments from patients at RASS -2/-3 (22 % of all assessments) were excluded. Similarly, the number of positive ICDSC results decreased from 51 to 29 % (p < 0.001). CONCLUSIONS: Sedation per se can result in positive items of both CAM-ICU and ICDSC, and therefore in a diagnosis of delirium. Consequently, apparent prevalence of delirium is dependent on how a depressed level of consciousness after sedation stop is interpreted (delirium vs persisting sedation). We suggest that any reports on delirium using these assessment tools should be stratified for a sedation score during the assessment.
Authors: Brenda Truman Pun; Sharon M Gordon; Josh F Peterson; Ayumi K Shintani; James C Jackson; Julie Foss; Sharon D Harding; Gordon R Bernard; Robert S Dittus; E Wesley Ely Journal: Crit Care Med Date: 2005-06 Impact factor: 7.598
Authors: Maarten M van Eijk; Mark van den Boogaard; Rob J van Marum; Paul Benner; Piet Eikelenboom; Marina L Honing; Ben van der Hoven; Janneke Horn; Gerbrand J Izaks; Annette Kalf; Attila Karakus; Ine A Klijn; Michael A Kuiper; Frank-Erik de Leeuw; Tjarda de Man; Roos C van der Mast; Robert-Jan Osse; Sophia E de Rooij; Peter E Spronk; Peter H van der Voort; Willem A van Gool; Arjen J Slooter Journal: Am J Respir Crit Care Med Date: 2011-05-11 Impact factor: 21.405
Authors: E W Ely; S K Inouye; G R Bernard; S Gordon; J Francis; L May; B Truman; T Speroff; S Gautam; R Margolin; R P Hart; R Dittus Journal: JAMA Date: 2001-12-05 Impact factor: 56.272
Authors: Matthias Haenggi; Heidi Ypparila; Jukka Takala; Ilkka Korhonen; Martin Luginbühl; Steen Petersen-Felix; Stephan M Jakob Journal: Anesth Analg Date: 2004-12 Impact factor: 5.108
Authors: E Wesley Ely; Ayumi Shintani; Brenda Truman; Theodore Speroff; Sharon M Gordon; Frank E Harrell; Sharon K Inouye; Gordon R Bernard; Robert S Dittus Journal: JAMA Date: 2004-04-14 Impact factor: 56.272
Authors: Stacie L Soja; Pratik P Pandharipande; Sloan B Fleming; Bryan A Cotton; Leanna R Miller; Stefanija G Weaver; Byron T Lee; E Wesley Ely Journal: Intensive Care Med Date: 2008-02-23 Impact factor: 17.440
Authors: Margaret A Pisani; So Yeon Joyce Kong; Stanislav V Kasl; Terrence E Murphy; Katy L B Araujo; Peter H Van Ness Journal: Am J Respir Crit Care Med Date: 2009-09-10 Impact factor: 21.405
Authors: E W Ely; S Gautam; R Margolin; J Francis; L May; T Speroff; B Truman; R Dittus; R Bernard; S K Inouye Journal: Intensive Care Med Date: 2001-11-08 Impact factor: 17.440
Authors: Dimitri Gusmao-Flores; Juliana C S Martins; Daniele Amorin; Lucas C Quarantini Journal: Intensive Care Med Date: 2013-10-03 Impact factor: 17.440
Authors: John W Devlin; Gilles L Fraser; Aaron M Joffe; Richard R Riker; Yoanna Skrobik Journal: Intensive Care Med Date: 2013-10-11 Impact factor: 17.440
Authors: Pratik P Pandharipande; E Wesley Ely; Rakesh C Arora; Michele C Balas; Malaz A Boustani; Gabriel Heras La Calle; Colm Cunningham; John W Devlin; Julius Elefante; Jin H Han; Alasdair M MacLullich; José R Maldonado; Alessandro Morandi; Dale M Needham; Valerie J Page; Louise Rose; Jorge I F Salluh; Tarek Sharshar; Yahya Shehabi; Yoanna Skrobik; Arjen J C Slooter; Heidi A B Smith Journal: Intensive Care Med Date: 2017-06-13 Impact factor: 17.440
Authors: Michael T Kenes; Joanna L Stollings; Li Wang; Timothy D Girard; E Wesley Ely; Pratik P Pandharipande Journal: Pharmacotherapy Date: 2017-10-17 Impact factor: 4.705
Authors: Joanna L Stollings; Jennifer L Thompson; Benjamin A Ferrell; Mika Scheinin; Grant R Wilkinson; Christopher G Hughes; Ayumi K Shintani; E Wesley Ely; Timothy D Girard; Pratik P Pandharipande; Mayur B Patel Journal: Ann Pharmacother Date: 2018-01-24 Impact factor: 3.154
Authors: M van den Boogaard; L Schoonhoven; E Maseda; C Plowright; C Jones; A Luetz; P V Sackey; P G Jorens; L M Aitken; F M P van Haren; R Donders; J G van der Hoeven; P Pickkers Journal: Intensive Care Med Date: 2014-01-18 Impact factor: 17.440
Authors: Tarek Sharshar; Giuseppe Citerio; Peter J D Andrews; Arturo Chieregato; Nicola Latronico; David K Menon; Louis Puybasset; Claudio Sandroni; Robert D Stevens Journal: Intensive Care Med Date: 2014-02-13 Impact factor: 17.440
Authors: Ary Serpa Neto; Fabienne D Simonis; Carmen S V Barbas; Michelle Biehl; Rogier M Determann; Jonathan Elmer; Gilberto Friedman; Ognjen Gajic; Joshua N Goldstein; Janneke Horn; Nicole P Juffermans; Rita Linko; Roselaine Pinheiro de Oliveira; Sugantha Sundar; Daniel Talmor; Esther K Wolthuis; Marcelo Gama de Abreu; Paolo Pelosi; Marcus J Schultz Journal: Intensive Care Med Date: 2014-05-09 Impact factor: 17.440